Insiders

02-06 GSK Chair Jonathan Symonds buys GBP53,000 in shares AN
02-04 GSK optimistic for 2026 after fourth-quarter results beat forecast AN
02-04 GSK's Specialty Medicines Drive Solid Results DJ
02-04 GSK forecasts slower sales growth in 2026 RE
02-04 GSK eyes sharper, faster drug development as new CEO signals growth plan RE
02-03 Rigel Pharmaceuticals, Inc. Appoints Michael P. Miller to Its Board of Directors CI
02-02 GSK cutting jobs in UK and US as part of ongoing R&D changes AN
01-30 Immunocore Holdings plc Announces Executive Changes CI
01-28 Omass Therapeutics Announces Board Changes CI
01-09 Croda International plc Announces Appointment of Jill Anderson as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees, Effective January 12, 2026 CI
01-08 Praxis Precision Medicines, Inc. Announces Management Changes CI
01-07 GSK plc Appoints Luke Victor Miels as Director, Effective January 1, 2026 CI
01-04 GSK PLC Announces Termination of Director Appointment of Emma Natasha Walmsley, Effective December 31, 2025 CI
12-30 GSK PLC outlook improves amid merger speculation Alphavalue
12-23 Vor Biopharma Inc Announces Board Appointments, Effective December 18, 2025 CI
11-24 Heidelberg Pharma AG Announces Chief Executive Officer Changes, Effective 24 November 2025 CI
11-10 Haleon plc Announces Board Changes CI
11-10 Haleon Names Vindi Banga as Chair DJ
11-09 Diageo Assures 'Good Progress' in CEO Hunt as Concern Grows Among Investors MT
11-08 Diageo has considered external candidates for CEO role, FT reports RE
11-08 Diageo considers external candidates for CEO role, including outgoing GSK boss, FT reports RE
11-03 Vor Bio Appoints Jeremy Sokolove as Chief Medical Officer CI
25-10-29 GSK lifts sales and profit outlook as Specialty Medicines unit shines AN
25-09-29 GSK Taps Miels as CEO With Walmsley Stepping Down MT
25-09-29 GSK Names Chief Commercial Officer as CEO Designate MT
No results for this search